Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | ALB | P02768 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 7/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 5/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | GPR6 | P46095 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6822132 | 0.85 | ALB (0.45) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A | |
| SCHEMBL6835713 | 0.83 | ALB (0.45) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A | |
| SCHEMBL6833211 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A | |
| SCHEMBL6833592 | 0.79 | ALB (0.41) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A | |
| SCHEMBL6833099 | 0.78 | ALB (0.42) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A | |
| SCHEMBL6834689 | 0.77 | SMN1; SMN2 (0.43) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A | |
| SCHEMBL6835611 | 0.77 | ALB (0.41) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A | |
| SCHEMBL6830333 | 0.77 | MAPT (0.49) | SMN1; SMN2HSD17B10ALBRAB9AALDH1A1 | |
| SCHEMBL6833254 | 0.76 | ALB (0.55) | ALBLMNAMAPT | |
| SCHEMBL6821753 | 0.76 | ALB (0.41) | SMN1; SMN2HSD17B10MAPK1ALBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | SMN1; SMN2 2022/4885HSD17B10 2592/4885MAPK1 2575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.